64 related articles for article (PubMed ID: 9830418)
1. Clinical outcomes of the Otago-Southland Breast Cancer Screening Programme 1991-1996.
Doyle TC; Elwood JM; Smale P; Berkeley BB; Blennerhassett JB; Miller AP; Chartres SM; Hunter MH; Packer SG; Pfeifer M
N Z Med J; 1998 Oct; 111(1075):380-3. PubMed ID: 9830418
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
3. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
Menon A; Devlin NJ; Richardson AK
N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
Richardson A; Graham P; Brown T; Smale P; Cox B
J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
[TBL] [Abstract][Full Text] [Related]
5. [Breast complaints during the Dutch nationwide breast cancer screening program: increased risk of referral and of breast cancer].
van Bon-Martens MJ; Klingenberg H; Dijkstra HA; Peeters PH
Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1067-71. PubMed ID: 11414168
[TBL] [Abstract][Full Text] [Related]
6. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of mass screening for breast cancer in the Somme district (France) between 1990 and 1996].
Ganry O; Peng J; Dubreuil A
Rev Epidemiol Sante Publique; 1999 Sep; 47(4):335-41. PubMed ID: 10519174
[TBL] [Abstract][Full Text] [Related]
8. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
Séradour B; Allemand H; Schaffer P
Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
[TBL] [Abstract][Full Text] [Related]
9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
10. The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer.
Sweeney KJ; Kell MR; Aziz NA; Prunty N; Holloway P; Kennedy M; Flanagan F; Kerin MJ
Ir Med J; 2007 Sep; 100(8):550-2. PubMed ID: 17955686
[TBL] [Abstract][Full Text] [Related]
11. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
12. Dutch digital breast cancer screening: implications for breast cancer care.
Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
[TBL] [Abstract][Full Text] [Related]
13. A survey of urban and rural participants in the Otago-Southland pilot breast cancer screening programme.
Richardson AK; Elwood JM; McNoe B; Bang E
N Z Med J; 1994 Feb; 107(971):36-8. PubMed ID: 8302502
[TBL] [Abstract][Full Text] [Related]
14. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
15. Population-based breast cancer screening: policy advice for a New Zealand screening programme. Breast Cancer Screening Policy Advisory Group.
N Z Med J; 1998 Apr; 111(1064):138-42. PubMed ID: 9612474
[TBL] [Abstract][Full Text] [Related]
16. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in mumbai, India. 2. Compliance to referral and treatment.
Dinshaw K; Mishra G; Shastri S; Badwe R; Kerkar R; Ramani S; Thakur M; Uplap P; Kakade A; Gupta S; Ganesh B
Oncology; 2007; 73(3-4):154-61. PubMed ID: 18408402
[TBL] [Abstract][Full Text] [Related]
17. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
18. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
19. Outcomes among women younger than age 40 in a state breast cancer screening program.
Vetto JT; Wheeler AJ; Toomey M; Schmidt KJ
Am J Surg; 2006 May; 191(5):635-40. PubMed ID: 16647351
[TBL] [Abstract][Full Text] [Related]
20. [Mammographic screening of the health district 38, hospital of Gardone Val Trompia (Brescia - Lombardy). Results of the first 2 rounds].
Nocivelli G; Bordiga G; Castellani M; Chiesa R; Donato F
Radiol Med; 1993 Dec; 86(6):815-9. PubMed ID: 8296001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
